| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6414114 Useful as agents in oxidation-reduction equilibrium in cells; enzyme regulation in homeostasis |
| 07/02/2002 | US6414113 Amino acid sequence of peptide; for purifying and detecting bone marrow stromal cell antigen-1 |
| 07/02/2002 | US6414112 Peptide nucleic acids having 2,6-diaminopurine nucleobases |
| 07/02/2002 | US6414014 Calibration dosage; side effect reduction |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413961 Perioperative delivery to surgical site of local anesthetic and other medicants; lower doses; anti-restenosis; anti-spasmotic; arthroscopy; cardiovascular and general vascular operations |
| 07/02/2002 | US6413948 Central nervous system disorders |
| 07/02/2002 | US6413943 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 07/02/2002 | US6413939 Inducible phosphofructokinase and the Warburg effect |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413935 Oligopeptide |
| 07/02/2002 | US6413934 Biotin binding zones |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413931 Peptide inhibitor of fibrinogen blood clotting |
| 07/02/2002 | US6413930 Controlling eye movement |
| 07/02/2002 | US6413771 Respiratory syncytial virus (rsv) fusion protein; treating or preventing rsv infection, as well as for diagnosis of rsv in analytes |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413760 Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof |
| 07/02/2002 | US6413759 Streptokinase mutants |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413755 Human checkpoint kinase, HCDS1, compositions and methods |
| 07/02/2002 | US6413740 Nucleic acid which codes for muscle specific kinase c-terminal fragment of human agrin; diagnosis and treatment of muscle disorders and neuromusclar disorders |
| 07/02/2002 | US6413738 House dust mite allergen, Der f VII, and uses therefor |
| 07/02/2002 | US6413737 Ecarin prothrombin protease and methods |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413732 Substrate analogs that substitute for lipid I as a substrate for MurG |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413730 Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase |
| 07/02/2002 | US6413550 Proteinoid carriers and methods for preparation and use thereof |
| 07/02/2002 | US6413547 Thermotropic; antibiotics; antiinflammatory agents; antihistamines |
| 07/02/2002 | US6413539 Block polymer |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413516 Suppression lymphocytes |
| 07/02/2002 | US6413515 Vaccines |
| 07/02/2002 | US6413514 Methods of using antibodies against human CD40 |
| 07/02/2002 | US6413513 Administering angiogenesis inhibitor; prostate specific antibodies or carcinoembryonic antigen |
| 07/02/2002 | US6413512 Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue |
| 07/02/2002 | US6413511 Cartilage alterations by administering to joints chondrocytes comprising a heterologous polynucleotide |
| 07/02/2002 | US6413510 Dimeric modified groβ protein |
| 07/02/2002 | US6413509 Expansion of stem cells |
| 07/02/2002 | US6413494 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 07/02/2002 | US6412492 Mixed chimerism and tolerance |
| 07/02/2002 | CA2253837C Therapeutic uses of bpi protein products for human meningococcemia |
| 07/02/2002 | CA2201714C Method for isolation of highly pure von willebrand factor |
| 07/02/2002 | CA2184908C Human osteoclast-derived cathepsin |
| 07/02/2002 | CA2167678C Radioactive peptides |
| 07/02/2002 | CA2133203C Hybrid human/porcine factor viii |
| 07/02/2002 | CA2109601C Amide derivatives of antibiotic a 40926 |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2082960C An apparatus for preparing a concentrate of coagulation factors, such as fibrinogen, from a blood sample |
| 07/02/2002 | CA2080008C Water-soluble mutein of fibroblast growth factor (fgf) receptor |
| 07/02/2002 | CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same |
| 07/02/2002 | CA2032527C Lytic peptides: their use in the treatment of microbial infections, cancer and in the promotion of growth |
| 06/27/2002 | WO2002050545A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 06/27/2002 | WO2002050304A2 Oncolytic virus |
| 06/27/2002 | WO2002050301A2 Gene expression profiles associated with osteoblast differentiation |
| 06/27/2002 | WO2002050290A1 A yeast expression vector and a method of making a recombinant protein by expression in a yeast cell |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050284A2 Oxidoreductases |
| 06/27/2002 | WO2002050283A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050278A2 Novel human secreted proteins and polynucleotides encoding the same |
| 06/27/2002 | WO2002050277A2 Protein and nucleic acids encoding same |
| 06/27/2002 | WO2002050276A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050275A2 Proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050265A1 Novel transmembrane receptor-like proteins and dnas thereof |
| 06/27/2002 | WO2002050263A2 Methods_for treating tissue damage by bone-marrow derived stem cells |
| 06/27/2002 | WO2002050261A2 PROTEINS THAT INTERACT WITH βTRCP |
| 06/27/2002 | WO2002050258A1 Novel aggrecanase |
| 06/27/2002 | WO2002050254A2 Crystal structure of glycogen synthase kinase 3 beta |
| 06/27/2002 | WO2002050250A2 Signal-1/signal-2 bifunctional peptide inhibitors |
| 06/27/2002 | WO2002050248A2 Antisense modulation of hepsin expression |
| 06/27/2002 | WO2002050247A2 Antisense modulation of hepsin expression |
| 06/27/2002 | WO2002050246A2 Treatment of bone disorders by modulation of fgfr3 |
| 06/27/2002 | WO2002050244A2 Antisense modulation of histone deacetylase 1 expression |
| 06/27/2002 | WO2002050243A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 06/27/2002 | WO2002050122A2 Means for the diagnosis and therapy of ctcl |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050117A2 G-proteins coupled receptor proteins and nucleic acids encoding same |
| 06/27/2002 | WO2002050116A2 Adhesion molecule protein |
| 06/27/2002 | WO2002050115A1 Modified tachykinin receptors |
| 06/27/2002 | WO2002050114A2 Modulation of atp-binding cassette transporter activity |
| 06/27/2002 | WO2002050113A2 Interleukin-1 related gene and protein |
| 06/27/2002 | WO2002050112A2 Isolation of purified tgf- 1 and tgf- 2 from bone tissue |
| 06/27/2002 | WO2002050111A2 Isolated laminin 10 |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050105A1 Novel compounds |
| 06/27/2002 | WO2002050103A2 Tumour-related antigens |
| 06/27/2002 | WO2002050102A2 Inhibitors of the e2f-1/cyclin interaction for cancer therapy |
| 06/27/2002 | WO2002050101A1 Retinoblastoma-binding protein |
| 06/27/2002 | WO2002050100A2 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery |
| 06/27/2002 | WO2002050097A2 Anti-allergic complex molecules |